摘要 |
<p>The invention relates to the use of racemic alpha-lipoic acid, enantiomers or pharmaceutically acceptable salts, amides, esters or thioesters thereof, in reduced or oxidized form, for the manufacture of a medicament for prevention or acute or chronic treatment of migraine.</p> |